{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0016477",
      "entity_text" : "cell migration",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ02147",
      "entity_text" : "miR-183",
      "features" : [ {
        "modification_type" : "unknown",
        "feature_type" : "modification"
      } ],
      "entity_type" : "gene_or_gene_product"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "The overexpression of miR-183, reflecting the downregulation of Ezrin, has been previously shown to inhibit breast cancer cell migration.",
  "reading_complete" : "2020-08-02T14:14:31Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T14:13:19Z",
  "trigger" : "inhibit",
  "evidence" : [ "miR-183, reflecting the downregulation of Ezrin, has been previously shown to inhibit breast cancer cell migration" ],
  "pmc_id" : "6192766",
  "score" : 0
}